Association of fatty acid composition of blood serum with bile lipid composition in cholelithiasis patients

Terapevticheskii Arkhiv

Volumn 80, Issue 2, 2008, Pages 71-75

  Tsukanov, V V ^a   Kuperstein, E Yu ^a   Tonkikh, Yu L ^a   Bronnikova, E P ^a  

^a NONE

Author keywords

Cholelithiasis; Fatty acids; Lipid metabolism

Indexed keywords

BILE ACID; BIOLOGICAL MARKER; FATTY ACID;

ADULT; ARTICLE; BILE; BLOOD; CHEMISTRY; CHOLELITHIASIS; COMPARATIVE STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PREVALENCE; RUSSIAN FEDERATION;

ADULT; BILE; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; CHOLELITHIASIS; CHROMATOGRAPHY, GAS; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RUSSIA;

EID: 42549141763     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bartoli E., Capron J. P. Epidemiology and natural history of cholelithiasis. Rev. Prat. 2000; 1 (19): 2112-2116.
2. Katsika D., Grjibovski A. et al. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43 141 twin pairs. Hepatology 2005; 41: 1138-1143.
3. Carey M. C. Molecular mechanisms controlling bile metabolism in health and disease. In: Disease progression and disease prevention in hepatology and gastroenterology. Dordrecht Springer; 2006. 3-13.
4. Van Mil S. W., van der Woerd W. L. et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127: 379-384.
5. Loria P., Lonardo A. et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J. Gastroenterol. Hepatol. 2005; 20 (8): 1176-1184.
6. Kurtul N., Pence S. et al. Serum lipid and lipoproteins in gallstone patients. Acta Med. (Hradec Kralove) 2002; 45 (2): 79-81.
7. Devesa F., Ferrando J. et al. Cholelithiasis disease and associated factors in a Spanish population. Dig. Dis. Sci. 2001; 46 (7): 1424-1436.
8. Gilat T., Somjen G. J. et al. Fatty acid bile acid conjugates (FABACs) - new molecules for the prevention of cholesterol crystallisation in bile. Gut 2001; 48 (1): 75-79.
9. Russian source
10. Thomas P. J., Hofmann A. F. A simple calculation of the lithogenic index of bile expressing biliary lipid composition on rectangular coordinates. Gastroenterology 1973; 65 (4): 698-700.
11. Abell L. L., Levy B. B. et al. A simplified method for estimation of total cholesterol in serum and demonstration of its specificity. J. Biol. Chem. 1952; 195 (1): 357-366.
12. Russian source
13. Trinder P. Ann. Clin. Biochem. 1969; 6: 24.
14. Russian source
15. Borch K., Jonsson K. A. et al. Prevalence of gallstone disease in a Swedish population sample. Scand J. Gastroenterol. 1998; 33 (11): 1219-1225.
16. Jitea N., Burcos T. et al. Analysis of 3100 laparoscopic cholecystectomies. Chirurgia (Buc). 2001; 96 (6): 553-557.
17. Ros A., Haglund B., Nilsson E. Reintervention after laparoscopic and open cholecystectomy in Sweden 1987-1995: analysis of data from a hospital discharge register. Eur. J. Surg. 2002; 168 (12): 695-700.
18. Akute O. O., Obajimi M. O. Cholelithiasis in Ibadan: an update. West. Afr. J. Med. 2002; 21 (2): 128-131.
19. Liu C. M., Tung T. H., Chou P. Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital. Wld. J. Gastroenterol. 2006; 28 (12, suppl. 8): 1281-1286.
20. Brasca A., Berli D. et al. Morphological and demographic associations of biliary symptoms in subjects with gallstones: findings from a population-based survey in Rosario, Argentina. Dig. Liver Dis. 2002; 34 (8): 577-581.
21. Russian source
22. Nilsell K., Angelin B. et al. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Gastroenterology 1985; 89 (2): 287-293.
23. Tsai C. J., Leitzmann F. et al. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann. Intern. Med. 2004; 141 (7): 514-522.